Literature DB >> 23669635

Do vitamin A serum levels moderate outcome or the protective effect of vitamin D on outcome from malignant melanoma?

Sinead Field1, Faye Elliott, Juliette Randerson-Moor, Kairen Kukalizch, Jennifer H Barrett, D Timothy Bishop, Julia A Newton-Bishop.   

Abstract

BACKGROUND & AIMS: Low serum vitamin D levels (25-OH-vit D2/3) are reported to be associated with thicker melanomas and poorer outcome. Vitamin A metabolites and vitamin D bind to the same heterodimeric receptor. We report a study testing the hypothesis that high vitamin A levels may reduce the protective effect of vitamin D on outcome.
METHODS: Serum vitamin A levels were measured in 795 melanoma cases and assessed for association with Breslow thickness, overall (OS) and melanoma-specific survival (MSS), and modification of the effect of vitamin D levels on survival.
RESULTS: Higher vitamin A levels (≥ 2.2 μmol/l) conferred a non-significant increased risk of melanoma-specific death (adjusted HR = 1.11, 95%CI(0.74-1.67), p = 0.60) but not for death overall (adjusted HR = 0.95, 95%CI(0.65-1.39), p = 0.79). There was reduction in the protective effect of vitamin D on OS in patients with high vitamin A levels (≥ 2.2 μmol/l)(HR = 0.99, 95%CI(0.72-1.36),p = 0.93) compared to patients with low levels (<2.2 μmol)(HR = 0.77, 95%CI(0.64-0.93),p = 0.007), although the difference was not statistically significant (p = 0.26).
CONCLUSIONS: High vitamin A levels may reduce the protective effect of vitamin D. As sub-optimal levels of vitamin D are common in temperate climates, and are usually managed by dietary supplementation, we suggest vitamin D3 supplementation alone might be preferable for melanoma patients than preparations containing vitamin D and A.
Copyright © 2013 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Dietary supplements; Melanoma; Survival; Vitamin A; Vitamin D

Mesh:

Substances:

Year:  2013        PMID: 23669635     DOI: 10.1016/j.clnu.2013.04.006

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  3 in total

Review 1.  From epidemiology and neurometabolism to treatment: Vitamin D in pathogenesis of glioblastoma Multiforme (GBM) and a proposal for Vitamin D + all-trans retinoic acid + Temozolomide combination in treatment of GBM.

Authors:  Ilhan Elmaci; Aysel Ozpinar; Alp Ozpinar; Jennifer L Perez; Meric A Altinoz
Journal:  Metab Brain Dis       Date:  2019-04-01       Impact factor: 3.584

Review 2.  The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis.

Authors:  P G Vaughan-Shaw; F O'Sullivan; S M Farrington; E Theodoratou; H Campbell; M G Dunlop; L Zgaga
Journal:  Br J Cancer       Date:  2017-03-16       Impact factor: 7.640

Review 3.  Vitamin D, vitamin A, the primary melanoma transcriptome and survival.

Authors:  S J O'Shea; J R Davies; J A Newton-Bishop
Journal:  Br J Dermatol       Date:  2016-10       Impact factor: 9.302

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.